Viewing Study NCT04100122



Ignite Creation Date: 2024-05-06 @ 1:43 PM
Last Modification Date: 2024-10-26 @ 1:18 PM
Study NCT ID: NCT04100122
Status: COMPLETED
Last Update Posted: 2023-05-06
First Post: 2019-09-17

Brief Title: Luminex-based Assay to Identify Major IgE-binding Episode Among IgE-mediated Wheat-allergic Patient
Sponsor: Mahidol University
Organization: Mahidol University

Study Overview

Official Title: Luminex-based Assay to Identify Major IgE-binding Episode Among IgE-mediated Wheat-allergic Patient
Status: COMPLETED
Status Verified Date: 2023-05
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This study will be using Luminex-based peptide assay LPA to determine major IgE-binding epitope among wheat allergic children to differentiate clinical phenotype
Detailed Description: Luminex-based peptide assay LPA is a novel tool using machine learning techniques developed to predict different degrees of food allergy has been successfully reported among cows milk protein allergy This technique provide a more precise and advanced adaptation from microarray-based immunoassay MIA Using this technique will aid us for the differentiation of clinical phenotypes of wheat-allergic patients This study will be the first study to date using this technique aim to determine major IgE-binding epitope among immediated-reaction of wheat allergic children to differentiate clinical phenotypes and may lead to further study to develop the new therapeutic approach to wheat-allergic patients

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None